Cargando…
Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
BACKGROUND: Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic. Aspirin eugenol ester (AEE) is a novel compound that exhibits efficacious anti-hyperlipidemia activities. However, its mechanisms are still not completely known....
Autores principales: | Ma, Ning, Liu, Xi-Wang, Kong, Xiao-Jun, Li, Shi-Hong, Jiao, Zeng-Hua, Qin, Zhe, Yang, Ya-Jun, Li, Jian-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299661/ https://www.ncbi.nlm.nih.gov/pubmed/30563510 http://dx.doi.org/10.1186/s12917-018-1711-x |
Ejemplares similares
-
Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia
por: Karam, Isam, et al.
Publicado: (2015) -
Untargeted lipidomics and metagenomics reveal the mechanism of aspirin eugenol ester relieving hyperlipidemia in ApoE−/− mice
por: Lu, Xiao-Rong, et al.
Publicado: (2022) -
Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1
por: Xiao-Rong, Lu, et al.
Publicado: (2021) -
Cellular Metabolomics Reveal the Mechanism Underlying the Anti-Atherosclerotic Effects of Aspirin Eugenol Ester on Vascular Endothelial Dysfunction
por: Huang, Mei-Zhou, et al.
Publicado: (2019) -
Aspirin Eugenol Ester Attenuates Paraquat-Induced Hepatotoxicity by Inhibiting Oxidative Stress
por: Zhang, Zhen-Dong, et al.
Publicado: (2020)